Percutaneous coronary intervention and the no-reflow phenomenon

Area of Science:

• Cardiology
• Interventional Cardiology

Background:

• No-reflow phenomenon is a significant complication during percutaneous coronary intervention (PCI).
• It is most frequently observed in saphenous vein graft interventions, rotational atherectomy, and primary PCI for acute ST-elevation myocardial infarction.
• The underlying causes, including distal embolization and ischemia/reperfusion injury, vary across these clinical scenarios.

Purpose of the Study:

• To review the pathogenesis, prevention, and management of the no-reflow phenomenon in PCI.
• To highlight the importance of prevention strategies in high-risk patient groups.
• To differentiate treatment approaches based on the cause of no-reflow.

Main Methods:

• Literature review focusing on the no-reflow phenomenon in PCI.
• Analysis of contributing factors such as distal embolization and ischemia/reperfusion injury.
• Evaluation of current prevention and treatment strategies.

Main Results:

• Prevention of distal embolization using antiplatelet agents, vasodilators, or mechanical devices is the primary strategy in high-risk PCI.
• Pharmacologic treatment is the mainstay for established no-reflow once mechanical causes are ruled out, targeting microvascular obstruction.
• Refractory no-reflow is associated with a substantially higher risk of 30-day mortality compared to transient no-reflow.

Conclusions:

• Proactive prevention of distal embolization is crucial for managing no-reflow during PCI.
• Effective treatment of established no-reflow relies on pharmacologic interventions targeting microvascular dysfunction.
• Understanding the varying contributions of embolization and ischemia/reperfusion is essential for optimizing patient outcomes and reducing mortality.